Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/20168106/ below:

Repeat pap testing and colposcopic biopsies in the underserved

Affiliations

• ¹ From the Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

• PMID: 20168106
• DOI: 10.1097/AOG.0b013e3181b8fc88

Item in Clipboard

Katrina F Trivers et al. Obstet Gynecol. 2009 Nov.

• ¹ From the Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

• PMID: 20168106
• DOI: 10.1097/AOG.0b013e3181b8fc88

Item in Clipboard

Objective: To quantify repeat Pap testing and colposcopic biopsies among women in the National Breast and Cervical Cancer Early Detection Program between 2003 and 2006 (N=955,494).

Methods: Rates of repeat Pap testing (two tests within 9 months) and colposcopic biopsies were estimated along with 95% confidence intervals (CIs). Odds ratios and 95% CIs for receipt of colposcopic biopsy compared with repeat Pap testing were estimated from multivariable logistic regression models. Finally, we estimated positive predictive values and 95% CIs of cervical intraepithelial neoplasia (CIN) 2 or worse (CIN 3, carcinoma in situ, invasive cancer) for two strategies: 1) repeat Pap testing followed by colposcopic biopsy and 2) colposcopic biopsy alone.

Results: There were 39,583 and 53,880 women with repeat Pap testing and colposcopic biopsy, respectively, from 2003 to 2006. Overall, age-standardized rates of repeat Pap testing and colposcopic biopsies were 37.2 per 1,000 women and 39.3 per 1,000 women, respectively. Younger women, Hispanic women, and African-American women were more likely to receive colposcopic biopsies compared with repeat Pap tests. Positive predictive values of colposcopic biopsy were highest after abnormal Pap test results (27% after a result of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, 70% after a result of high-grade squamous intraepithelial lesion/squamous cell cancer).

Conclusion: Colposcopic biopsies are common among young women after being screened for cervical cancer and, except among those with the most severe Pap test results, may not be efficient in detecting serious disease. These results conflict with current recommendations for less aggressive follow-up for most young women.

Level of evidence: II.

PubMed Disclaimer

• Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.

  Le T, Hicks W, Menard C, Boyd D, Hewson T, Hopkins L, Kee Fung MF. Le T, et al. J Obstet Gynaecol Can. 2004 Sep;26(9):788-92. doi: 10.1016/s1701-2163(16)30149-9. J Obstet Gynaecol Can. 2004. PMID: 15361273

• Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.

  Howell LP, Gurusinghe S, Tabnak F, Sciortino S. Howell LP, et al. Cancer Detect Prev. 2009;32(5-6):372-9. doi: 10.1016/j.cdp.2009.02.001. Epub 2009 Mar 4. Cancer Detect Prev. 2009. PMID: 19264426

• [Optimizing biopsy procedures during colposcopy and detection of high-grade cervical lesions].

  Tang MY, You ZX. Tang MY, et al. Zhonghua Fu Chan Ke Za Zhi. 2021 Mar 25;56(3):192-199. doi: 10.3760/cma.j.cn112141-20201010-00765. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 33874714 Chinese.

• Is colposcopic biopsy overused among women with a cytological diagnosis of atypical squamous cells of undetermined significance (ASCUS)?

  Lousuebsakul V, Knutsen SM, Singh PN, Gram IT. Lousuebsakul V, et al. J Womens Health (Larchmt). 2003 Jul-Aug;12(6):553-9. doi: 10.1089/154099903768248258. J Womens Health (Larchmt). 2003. PMID: 13678510

• The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.

  Melinte-Popescu A, Costăchescu G. Melinte-Popescu A, et al. Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):536-9. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23077949

• Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.

  Watson M, Benard V, Lin L, Rockwell T, Royalty J. Watson M, et al. Cancer Causes Control. 2015 May;26(5):759-64. doi: 10.1007/s10552-015-0549-9. Epub 2015 Mar 21. Cancer Causes Control. 2015. PMID: 25794897 Free PMC article.

• Utilization and outcomes of serial cervical cancer screening in a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in a non-Medicaid expansion state.

  Ratnaparkhi R, Ismail A, Krebill H, Cook I, Javellana M, Jewell A, Spoozak L, Emerson A, Ramaswamy M, Calhoun E, Mudaranthakam DP. Ratnaparkhi R, et al. Cancer Causes Control. 2025 Apr;36(4):409-420. doi: 10.1007/s10552-024-01948-3. Epub 2024 Dec 16. Cancer Causes Control. 2025. PMID: 39681764 Free PMC article.

• Using data to effectively manage a national screening program.

  Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Yancy B, et al. Cancer. 2014 Aug 15;120 Suppl 16(0 16):2575-83. doi: 10.1002/cncr.28821. Cancer. 2014. PMID: 25099900 Free PMC article.

• Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasia.

  Tian X, Chen D, Zhang R, Zhou J, Peng X, Yang X, Zhang X, Zheng Z. Tian X, et al. Clin Epigenetics. 2015 Jan 22;7(1):4. doi: 10.1186/s13148-014-0037-1. eCollection 2015. Clin Epigenetics. 2015. PMID: 25699113 Free PMC article.

1. 1. Ryerson AB, Benard VB, Major AC. The National Breast and Cervical Cancer Early Detection Program 1991–2002 national report. Atlanta (GA): Department of Health and Human Services; 2005.
2. 1. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, et al. Comparison of screening mammography in the United States and the United Kingdom [published erratum appears in JAMA 2004;291:824]. JAMA 2003;290:2129–37.
3. 1. Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstet Gynecol 2007;110:681–6.
4. 1. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003;349:1501–9.
5. 1. Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001. Obstet Gynecol 2004;103:564–71.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3